Search results for "Drug costs"
Factoring drug costs into diabetes decisions
A sizable number of patients with diabetes do not consistently fill their prescriptions or take less than the prescribed amount due to costs, but there are ways to make it easier on a patient's pocketbook.
https://immattersacp.org/archives/2022/05/factoring-drug-costs-into-diabetes-decisions.htm
1 May 2022
ACP recommends policies to curb prescription drug costs
Transparency in pricing, cost, and comparative value and elimination of restrictions on using quality-adjusted life-years in comparative effectiveness research are 2 of the recommendations.
https://immattersacp.org/weekly/archives/2016/03/29/2.htm
29 Mar 2016
Examining cost effects of ‘skinny-label’ generics
A federal ruling over a patent dispute could lead to long-term effects on health care spending in the United States, a recent study indicated.
https://immattersacp.org/archives/2024/11/examining-cost-effects-of-skinny-label-generics.htm
1 Nov 2024
Studies, CMS look at lowering prescription prices
Even as Medicare seeks to negotiate down the costs of 10 prescription drugs, researchers are examining the effectiveness of existing private programs to provide lower drug costs and copays.
https://immattersacp.org/weekly/archives/2023/09/05/1.htm
5 Sep 2023
Alzheimer's disease, early-onset cancer, and more stories
This month's issue covers Alzheimer's disease, breast cancer mutations, and "skinny label" generic drugs.
https://immattersacp.org/archives/2024/11/alzheimers-disease-early-onset-cancer-and-more-stories.htm
1 Nov 2024
One-fifth of COVID-19 patients taking nirmatrelvir-ritonavir had viral rebound
A small observational study of ambulatory patients with COVID-19 found that 1.8% of untreated patients tested positive again after testing negative, compared to 20.8% of those who took five days of nirmatrelvir-ritonavir.
https://immattersacp.org/weekly/archives/2023/11/14/4.htm
14 Nov 2023
ACP's prescription for rising drug costs
ACP has 4 concrete proposals to address rising prescription drug prices: regulating and negotiating prices, enhancing transparency, increasing competition, and considering value.
https://immattersacp.org/archives/2016/05/washington.htm
1 May 2016
Research looks at out-of-pocket prescription costs
One study evaluated the effect of real-time pop-up recommendations for lower-priced prescription alternatives, while a second study modeled capping monthly expenses and shifting the patients' savings back to the insurance plan.
https://immattersacp.org/weekly/archives/2022/09/20/2.htm
20 Sep 2022
Democrats must reconcile to pass reconciliation
As the Democratic leadership moves forward with their slim majorities in Congress, they must agree among themselves on trillions of dollars of health care programs, including universal health care, Medicare expansion, and more tax subsidies for the Affordable Care Act.
https://immattersacp.org/archives/2021/10/democrats-must-reconcile-to-pass-reconciliation.htm
1 Oct 2021
ACP calls for increased competition in prescription drug market
The new policy paper is the third installment of a series. Previous papers have offered recommendations related to public health programs and pharmacy benefit managers.
https://immattersacp.org/weekly/archives/2020/09/15/6.htm
15 Sep 2020